This study aims to help children with sickle cell disease (SCD) who may have trouble with attention, memory, and decision-making. Sickle cell disease is a blood disorder that can cause pain and other health issues. The study will test a medicine called Methylphenidate (MPH) to see if it can improve thinking and schoolwork in these children. Methylphenidate is a medication often used to help people pay attention and control their behavior.
Thirty children, ages 8 to 17, will take the medicine once a day for 4 weeks. Caregivers will help track any changes in thinking abilities and watch for side effects. The study will also interview caregivers to understand their decisions about using this medicine.
- Study lasts for 4 weeks with daily medication.
- Participants must visit the clinic initially, then take the medicine at home.
- Potential side effects and benefits will be carefully monitored and discussed.
How understandable was the trial content above?
Hard to understand
Easy to understand